Supplementary Table 3 from Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates

Candace L. Haddox, Michael J. Nathenson,Emanuele Mazzola,Jia-Ren Lin, Joanna Baginska, Allison Nau,Jason L. Weirather,Edwin Choy,Adrian Marino-Enriquez, Jeffrey A. Morgan, Gregory M. Cote,Priscilla Merriam,Andrew J. Wagner,Peter K. Sorger,Sandro Santagata,Suzanne George

crossref（2024）

引用 0|浏览5

暂无评分

摘要

Supplementary Table 3. Soft tissue cancer statistics with respect to incidence, age, race/ethnicity, and geographical distribution in the United States.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要